Overview: Ibrunat 140 mg Capsules contain Ibrutinib (140 mg) and are prescribed as an oral targeted anticancer medicine for the treatment of certain B-cell malignancies including mantle cell lymphoma (MCL) and chronic lymphocytic leukemia (CLL) by inhibiting Bruton’s tyrosine kinase, a key signaling protein in malignant B-cells. Key Benefits: – Targets Bruton’s tyrosine kinase to slow cancer cell signaling and proliferation – Oral dosing for convenient outpatient therapy – Used in specific B-cell malignancies including MCL and CLL Composition: Ibrutinib (140 mg) How It Works: Ibrutinib selectively inhibits Bruton’s tyrosine kinase (BTK), which plays a crucial role in the growth and survival of B-cell malignancies, thereby reducing tumor cell proliferation and disease progression. Usage Instructions: – Take exactly as directed by your healthcare provider – Swallow the capsule whole with water, with or without food – Do not crush or chew the capsule Side Effects: – Diarrhea, nausea, vomiting – Fatigue, rash, muscle pain – Low blood counts and increased infection risk Precautions: – Not recommended during pregnancy or breastfeeding — consult healthcare provider before use – Monitor blood counts and liver function regularly during treatment – Inform your doctor of all current medications Storage Instructions: – Store below 30°C in a cool, dry place away from moisture and light Manufacturer: Generic Pharmaceuticals Disclaimer: To be sold by retail on the prescription of a registered medical practitioner only.